scispace - formally typeset
H

Herman C. B. Denber

Researcher at Columbia University

Publications -  28
Citations -  185

Herman C. B. Denber is an academic researcher from Columbia University. The author has contributed to research in topics: Mescaline & Occupational therapy. The author has an hindex of 8, co-authored 28 publications receiving 182 citations.

Papers
More filters
Journal ArticleDOI

Studies on mescaline. I. Action in schizophrenic patients; clinical observations and brain wave patterns, showing effects before and after electric convulsive treatments.

TL;DR: The intravenous injection of 0.5 grams of mescaline sulfate in 25 schizophrenic patients produced a varied clinical picture, with a predominance of emotional over ideational reactions, and did not affect the structure of the psychosis.
Journal ArticleDOI

Comparative analysis of the action of butyrylperazine at Manhattan State Hospital and the University Psychiatric Clinic at Erlangen.

TL;DR: It is suggested that genetic factors may play some role in explaining at least two of the significant differences between both groups in dosage requirements, side effects, and clinical results.
Journal ArticleDOI

A note on some therapeutic implications of the mescaline-induced state.

TL;DR: The clinical and laboratory data following the inections of mescaline sulfate and chlorpromazine hydrochloride are reported and the psychodynamic factors implicated in the clinical remissions are investigated under rigidly controlled conditions.
Journal ArticleDOI

Studies on mescaline XI: Biochemical findings during the mescaline-induced state with observations on the blocking action of different psychotropic drugs

TL;DR: In a comparative clinical analysis of the antagonism of various phenothiazines to mescaline, it was found that ehlorpromazine and triflupromazine were most effeetive, and proetorperazine and thiopropazate were only moderately effective.
Journal ArticleDOI

Problems in evaluation of R-1625.

TL;DR: It was not possible to influence the clinical picture in 21 of 30 acute and chronic female psychotic patients following treatment with R-1625.